Core Viewpoint - Chengdu Xian Dao (688222.SH) experienced a decline of 4.5% to close at 23.63 yuan, with a total market capitalization of less than 10 billion yuan following a share reduction announcement by major shareholders [1] Summary by Relevant Categories Company Performance - The stock opened at 24.22 yuan, reached a high of 25.68 yuan, and a low of 23.44 yuan during the trading session [1] - The trading volume was 31.5 thousand shares, with a total transaction value of 7.67 million yuan [1] - The company has a total market capitalization of 9.46 billion yuan and a price-to-earnings ratio (P/E) of 144.09 [1] Shareholder Actions - Major shareholders, including Lhasa Economic and Technological Development Zone Huabo Medical Device Co., Ltd. and Shenzhen Jun Tian Investment Enterprise (Limited Partnership), plan to reduce their holdings by up to 5 million shares, representing no more than 1.25% of the company's total share capital [1] - The company has announced share reduction plans five times in the past three years [1]

据统计，8月4日，盘后包括达意隆、山外山、开普检测、吉宏股份、红旗连锁、通达股份、神火股份、 康泰医学、步科股份、飞鹿股份、能辉科技、晶雪节能、胜宏科技、赛腾股份、雪迪龙、中芯国际、工 大高科、成都先导、飞乐音响、华电辽能、三维股份、奥锐特在内的22家A股上市公司披露减持情况。 当日暂无A股上市公司披露增持情况。 | 1 | 达意障 | 董事兼高级管理人员吴小满计划减持不超过4.22万股股份 | | --- | --- | --- | | 2 | 山外山 | 大健康和力远健鲲合计减持2.26%公司股份 | | 3 | 开普检测 | 副总经理贺春、张冉拟减持不超过0.54%公司股份 | | 4 | 吉宏股份 | 毒事长干亚朋计划减持不超过304万股 | | 5 | 红旗连锁 | 永辉超市拟减持不超过1%股份 | | 6 | 通达股份 | 控股股东拟减持不超过3%公司股份 | | 1 | 神火股份 | 普天工贸拟减持0.90%公司股份 | | 8 | 康泰医学 | 持股5%以上股东及部分董事、高管拟减持不超过3.59%股份 | | 9 | 步科股份 | 控股股东上海步进计划减持不超过3%公司股份 | | 10 | ...

Shareholder Reduction - Yonghui Supermarket plans to reduce its holdings by no more than 13.6 million shares in Hongqi Chain [1] - The controlling shareholder of Buke Co., Shanghai Bujin, intends to reduce its stake by no more than 3% [1] - The controlling shareholder of Tongda Co., Shi Wanfeng, plans to reduce its holdings by no more than 3% [1] - Changrun Industrial Company, a shareholder of Jingxue Energy, intends to reduce its stake by no more than 3% [1] - Shenzhen Jun Tian and Huabo Medical, shareholders of Chengdu Xian Dao, plan to collectively reduce their holdings by no more than 5 million shares [1] - Lingang Group, a shareholder of Feile Audio, intends to reduce its stake by no more than 1.1823% [1] - Energy Investment Group, a shareholder of Huadian Liaoning Energy, plans to reduce its holdings by no more than 14.7271 million shares [1] - Chiyao No. 10 Investment Fund, a shareholder of Sanwei Co., intends to reduce its stake by no more than 10.3116 million shares [1] - The deputy general manager of Kaipu Testing, He Chun, plans to reduce his holdings by no more than 390,000 shares [1] - Putian Gongmao, a shareholder of Shenhuo Co., intends to reduce its stake by no more than 0.90% [1] - Executive Luo Lianming of Nenghui Technology plans to reduce his holdings by no more than 20,000 shares [1] Other Notable Events - Director Hong Luyuan of *ST Yuancheng is under investigation for serious violations of discipline and law [1] - Xuan Zhi Information has terminated its investment in Tian Di Yi Ti Digital Industry Development Fund (Tianjin) Partnership [1]

Group 1 - Nanjing Bank's shareholder Nanjing High-Tech increased its shareholding from 8.94% to 9% [1] - Xuedilong plans to reduce its holdings by no more than 1% of the company's total share capital [1] - Sanwei Co., Ltd.'s shareholder Chi Yao No. 10 Investment Fund intends to reduce its holdings by no more than 1% of the company's shares [1] Group 2 - Chengdu XianDao's shareholders plan to collectively reduce their holdings by no more than 5 million shares [1]

Core Viewpoint - Chengdu Xian Dao (688222) announced that shareholders Shenzhen Jun Tian and Hua Bo Equipment plan to reduce their holdings through centralized bidding transactions, with a total of 5 million shares to be sold, representing approximately 1.25% of the company's total share capital [1] Summary by Relevant Categories Shareholder Reductions - Shenzhen Jun Tian intends to reduce its holdings by 2 million shares, which is about 0.5% of the total share capital [1] - Hua Bo Equipment plans to reduce its holdings by up to 3 million shares, accounting for approximately 0.75% of the total share capital [1] Current Shareholding Status - As of the announcement date, Shenzhen Jun Tian holds 11.9272 million shares, representing 2.98% of the total share capital [1] - Hua Bo Equipment holds 44.7706 million shares, which is 11.17% of the total share capital [1]

华博器械拟通过集中竞价交易的方式减持其所持有的公司股份不超过300万股，拟减持股份占公司总股 本的比例约为0.75%，自减持计划发布之日起15个交易日之后的3个月内（2025年8月26日至2025年11月 25日）实施，且任意连续90个自然日内减持的股份总数不超过公司股份总数的1%。 格隆汇8月4日丨成都先导(688222.SH)公布，深圳钧天拟通过集中竞价交易的方式减持其所持有的公司 股份合计200万股，拟减持股份占公司总股本的比例约为0.50%，自减持计划发布之日起3个交易日之后 的3个月内（2025年8月8日至2025年11月7日）实施，根据《上海证券交易所上市公司创业投资基金股东 减持股份实施细则》，经过主管机构审批，任意连续30个自然日内减持的股份总数不超过公司股份总数 的1%。 ...

证券代码：688222 证券简称：成都先导 公告编号：2025-029 成都先导药物开发股份有限公司 关于股东减持股份计划公告 本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律 责任。 重要内容提示： 本次减持计划的股东深圳市钧天投资企业（有限合伙）（以下简称"深圳钧 天"）、拉萨经济技术开发区华博医疗器械有限公司（以下简称"华博器械"） 有关于减持意向的承诺： （1）减持方式：减持成都先导药物开发股份有限公司（以下简称"公司"、"发行 人"）股份应符合相关法律、法规、规章的规定，具体方式包括但不限于交易所 集中竞价交易方式、大宗交易方式、协议转让方式等； 3,000,000 股，拟减持股份占公司总股本的比例约为 0.75%，自减持计划发布之 日起 15 个交易日之后的 3 个月内（2025 年 8 月 26 日至 2025 年 11 月 25 日）实 施，且任意连续 90 个自然日内减持的股份总数不超过公司股份总数的 1%。 | 股东名称 | 拉萨经济技术开发区华博医疗器械有限公司 | | | --- | --- | ...

人民财讯8月4日电，成都先导(688222)8月4日晚间公告，股东深圳市钧天投资企业(有限合伙)拟通过集 中竞价交易的方式减持其所持有的公司股份合计200万股，拟减持股份占公司总股本的比例约为0.5%； 拉萨经济技术开发区华博医疗器械有限公司拟通过集中竞价交易的方式减持其所持有的公司股份不超过 300万股，拟减持股份占公司总股本的比例约为0.75%。 ...

成都先导公告，深圳钧天持股1192.72万股，占2.98%，拟于2025年8月8日至2025年11月7日通过集中竞 价减持不超过200万股，占0.50%，任意连续30日内减持总数不超过公司股份总数的1%；华博器械持股 4477.06万股，占11.17%，拟于2025年8月26日至2025年11月25日通过集中竞价减持不超过300万股，占 0.75%，任意连续90日内减持总数不超过公司股份总数的1%。 ...

证券之星消息，8月4日医疗服务板块较上一交易日下跌0.26%，昭衍新药领跌。当日上证指数报收于 3583.31，上涨0.66%。深证成指报收于11041.56，上涨0.46%。医疗服务板块个股涨跌见下表： | 代码 | 名称 | 收盘价 | 涨跌幅 | 成交量(手) | | 成交额(元) | | --- | --- | --- | --- | --- | --- | --- | | 688265 | 南模生物 | 43.73 | 20.01% | | 4.08万 | 1.66亿 | | 688621 | 阳光诺和 | 66.54 | 14.84% | | 12.60万 | 8.15亿 | | 301201 | 诚达药业 | 28.10 | 4.04% | | 10.58万 | 2.93亿 | | 688222 | 成都先导 | 24.74 | 3.82% | | 33.55万 | 7.91亿 | | 002172 | 澳洋健康 | 4.25 | 3.41% | | 70.07万 | 2.93亿 | | 688046 | 药康生物 | 16.41 | 3.01% | | 4.55万 | 7293.23万 | | ...